[Form 4] Doximity, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Doximity, Inc. (DOCS) director reported receiving 31,064 restricted stock units (RSUs) on November 15, 2025 under the company’s 2021 Stock Option and Incentive Plan. The RSUs vest in 10 equal quarterly installments after that date, contingent on the director’s continued service with the company at each vesting date. Each RSU converts into one share of Doximity Class A common stock at settlement, awarded at a stated price of $0 per share. Following this grant, the director beneficially owns 50,903 shares of Doximity Class A common stock in total.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Benjamin Regina M.

(Last) (First) (Middle)

C/O DOXIMITY, INC.

500 THIRD STREET

(Street)

SAN FRANCISCO CA 94107

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Doximity, Inc. [ DOCS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	11/15/2025		A		31,064(1)	A	$0	50,903	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares represent restricted stock units (each, an "RSU") granted on November 15, 2025 pursuant to the Doximity, Inc. 2021 Stock Option and Incentive Plan, which vest in 10 equal quarterly installments after November 15, 2025, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Remarks:

	/s/ Anna Bryson, Attorney-in-Fact	11/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Doximity (DOCS) report on November 15, 2025?

Doximity (DOCS) reported that a director received 31,064 restricted stock units (RSUs) of Class A common stock on November 15, 2025 under the 2021 Stock Option and Incentive Plan.

How do the new Doximity (DOCS) RSUs vest for the director?

The 31,064 RSUs granted to the Doximity director vest in 10 equal quarterly installments after November 15, 2025, subject to continued service on each vesting date.

What does each Doximity (DOCS) RSU represent in this Form 4 filing?

Each RSU granted to the Doximity director represents a contingent right to receive one share of Doximity’s Class A common stock upon vesting and settlement.

What was the reported acquisition price of the Doximity (DOCS) RSUs?

The director’s 31,064 Doximity RSUs were reported as acquired at a price of $0 per share, consistent with typical equity award grants.

How many Doximity (DOCS) shares does the director own after this RSU grant?

After the reported RSU grant, the director is shown as beneficially owning 50,903 shares of Doximity Class A common stock.

Under which plan were the Doximity (DOCS) RSUs granted?

The 31,064 RSUs were granted pursuant to the Doximity, Inc. 2021 Stock Option and Incentive Plan.